Oventus CEO and founder, Dr Chris Hart recently presented at the NWR’s Virtual Health Conference, providing an update to investors on Oventus’ progress and discussing our strategic response to COVID-19.
During the presentation, Dr Hart discusses:
- An overview of Obstructive Sleep Apnoea (OSA);
- What is driving adoption of Oventus’ Lab in Lab Model;
- Oventus’ strategic response to COVID-19, which includes use of telehealth and other remote procedures;
- How Oventus and its sleep partners are helping frontline workers in Canada suffering with OSA during the current pandemic; and
- The U.S. home-care model, which is in the late stages of development and expected to be rolled out in the U.S. shortly.
To watch the presentation, CLICK HERE, register your details and press ‘Play’.
Any investors interested in a direct update are invited to contact Jane Lowe via jane.lowe@irdepartment.com.au or +61 411 117 774.
Leave a Reply